Mikko Möttönen named Innovation Professor of the year by the CTO Forum
The CTO of the Year Awards are given by Technology Industries of Finland, Business Finland and innovation consulting company Spinverse to highlight the importance of Chief Technology Officers’ work on the future competitiveness of Finnish industry. Mikko Möttönen is the head of the Quantum Computing and Devices research group that is a part of the Academy of Finland Centre of Excellence in Quantum Technology (QTF). He holds a joint professorship in the Department of Applied Physics at Aalto University and VTT Technical Research Centre of Finland. He is also one of the four founders of and the Chief Scientist of the company.
Professor Möttönen said ‘We are on the verge of the biggest technology transition of our times. I am very touched upon receiving this award and the large number of stakeholders who want to contribute to the development of quantum technologies.’
The Director General and CEO of Business Finland Nina Kopola welcomes the new award category: ‘The collaboration between companies and universities is at its best in ecosystems led by companies and where the professors have the full support of their organisation for the activities. It is important to have more and more of such collaboration in Finland.’
You can read the full announcement on the CTO Forum website . For more information about IQM Quantum Computers, you can visit their website .
Contact:
Mikko Möttönen
Professor
Aalto University
(+358)505940950
mikko.mottonen@aalto.fi
Read more news
ACRIS service restored
The ACRIS research information management system is now open following the planned service break on 13–20 April 2026.
Science must have a voice in society – but how?
Trust in science has fallen in Finland by almost ten percentage points in two years
Meet our startup: Proteins.1 aims for a breakthrough in early disease detection
Biotechnology startup Proteins.1 is developing a technology that could enable the detection of diseases such as cancer months, or even years, earlier than is currently possible. The key lies in identifying individual proteins from a blood sample.